CanBreed is confident that the integration of CRISPR technology into its breeding program, combined with its unique transformation technology, will significantly accelerate its efforts to supply farmers with cannabis varieties endowed with improved, economically critical agronomic traits.
Corteva Agriscience and the Broad Institute of MIT and Harvard have extended the license as part of their nonexclusive open licensing framework. Consistent with compliance and stewardship requirements established by the organizations, the technology must be used in accordance with all applicable international, federal, and state laws and will not be used to enhance Tetrahydrocannabinol (THC), the chemical responsible for most of the psychotropic effects of cannabis. All research, development, and commercial activities related to the license will be conducted by CanBreed, and not Corteva or the Broad.
Make a free website with Mobirise